Results 41 to 50 of about 17,459 (201)

Expanding prevention of invasive meningococcal disease

Expert Review of Vaccines, 2009
Invasive meningococcal disease due to serogroups A, C, Y and W-135 is a serious, vaccine-preventable, worldwide public-health problem. Despite early treatment and advances in medical care, morbidity and mortality rates have essentially remained unchanged.
Stephen I, Pelton, Gregory P, Gilmet
openaire   +2 more sources

Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008. [PDF]

, 2016
BackgroundAlthough human immunodeficiency virus (HIV) infection is an established risk factor for several bacterial infections, the association between HIV infection and meningococcal disease remains unclear.MethodsExpanded chart reviews were completed ...
Clark, Thomas A, Cohn, Amanda C, Farley, Monica M, Hall, H Irene, Harris, Christine M, Harrison, Lee H, Lee, Adria, Li, Jianmin, Lynfield, Ruth, MacNeil, Jessica R, Miller, Lisa, Nichols, Megin, Petit, Susan, Reingold, Arthur, Schaffner, William, Thomas, Ann, Wu, Henry M, Zell, Elizabeth   +17 more
core   +2 more sources

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009. [PDF]

, 2016
In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation ...
Anderson, Raydel, Blain, Amy, Clark, Thomas, Cohn, Amanda, Farley, Monica, Harcourt, Brian, Harrison, Lee, Lynfield, Ruth, MacNeil, Jessica, Mandal, Sema, Mayer, Leonard, Miller, Lisa, Nichols, Megin, Petit, Sue, REINGOLD, Arthur L., Schaffner, William, Thomas, Ann, Wu, Henry, Zansky, Shelley   +18 more
core   +2 more sources

A Vaccine Against Group B Streptococcus: Recent Advances [PDF]

, 2020
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World ...
Carreras-Abad, C, Heath, PT, Le Doare, K, Ramkhelawon, L   +3 more
core   +2 more sources

Control of invasive meningococcal disease

International Journal of Evidence-Based Healthcare, 2016
Neisseria meningitidis still leads to deaths and severe disability in children, adolescents and adults. Six different capsular groups of N. meningitidis cause invasive meningococcal disease in the form of meningitis and septicaemia in humans. Although conjugate meningococcal vaccines have been developed to provide protection against four of the ...
Marshall, H, Wang, B, Wesselingh, S, Snape, M, Pollard, A   +4 more
openaire   +3 more sources

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence [version 1; peer review: 2 approved]

Wellcome Open Research, 2019
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher, Charlene M. C. Rodrigues, Adam Finn, Mandy Wootton, J. Claire Cameron, Andrew Smith, Paul Heath, Shamez Ladhani, Matthew D. Snape, Andrew J. Pollard, Richard Cunningham, Raymond Borrow, Caroline Trotter, Stephen J. Gray, Martin C. J. Maiden, Jenny M. MacLennan   +15 more
doaj   +1 more source

Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease

Canada Communicable Disease Report, 2020
Background: Trumenba™, a bivalent, factor-H binding protein meningococcal serogroup B (MenB-fHBP) vaccine was authorized for use in Canada in October 2017 for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis ...
Robyn Harrison, Robert Stirling, Oliver Baclic, Wendy Vaudry   +3 more
doaj   +1 more source

Self Mutilating Behaviour in Severe Meningococcal Infection; An Interesting Association [PDF]

Journal of Clinical and Diagnostic Research, 2016
Neisseria meningitidis most commonly manifests as asymptomatic colonization in the nasopharynx of healthy adolescents and adults. It may rarely present as invasive disease which may be either bacterial meningitis or meningococcal septicaemia.
Anju Dinkar, Jitendra Singh, Virendra Atam, Krishna Kumar Sahani, Munna Lal Patel   +4 more
doaj   +1 more source

From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood [version 1; referees: 3 approved] [PDF]

, 2017
In the past century, advances in antibiotics and vaccination have dramatically altered the incidence and clinical outcomes of bacterial meningitis. We review the shifting epidemiology of meningitis in children, including after the implementation of ...
Janowski, Andrew B, Newland, Jason G
core   +3 more sources

Current safety issues with quadrivalent meningococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source